Market Activity
Aptevo Therapeutics (APVO) Stock on a roll after Tang Capital Partners Discloses 54.40% Stake in APVO
Aptevo stock is trading in its highest range since Oct. 2018 as the biotech firm updates on completeremission of APVO436 while Tang discloses its stake in the company. The clinical-stage biotech firm, Aptevo Therapeutics Inc. (APVO) shares are on a roll from the start of this month and currently trading at its highest price range since Oct. 2018. Entering into November 2020, the stock market seems to ease the burden of pandemic and with the news of virus vaccine on the line, stocks are eyeing for a bullish run. On Monday, APVO stock surged up to 38.14% to $32.74 at the
